Hims & Hers HealthHIMS
HIMS
About: Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
Employees: 1,046
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
41% more call options, than puts
Call options by funds: $95.3M | Put options by funds: $67.6M
40% more funds holding in top 10
Funds holding in top 10: 5 [Q2] → 7 (+2) [Q3]
18% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 55
10% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 90
3% more funds holding
Funds holding: 291 [Q2] → 301 (+10) [Q3]
2.32% less ownership
Funds ownership: 64.41% [Q2] → 62.09% (-2.32%) [Q3]
11% less capital invested
Capital invested by funds: $2.68B [Q2] → $2.38B (-$303M) [Q3]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$18
31%
downside
Avg. target
$28
9%
upside
High target
$42
60%
upside
7 analyst ratings
4 positive
57%
2 neutral
29%
1 negative
14%
Morgan Stanley Craig Hettenbach 60% 1-year accuracy 3 / 5 met price target | 60%upside $42 | Overweight Initiated | 17 Dec 2024 |
Canaccord Genuity Maria Ripps 61% 1-year accuracy 17 / 28 met price target | 45%upside $38 | Buy Maintained | 2 Dec 2024 |
TD Cowen Jonna Kim 100% 1-year accuracy 4 / 4 met price target | 7%upside $28 | Buy Reiterated | 20 Nov 2024 |
B of A Securities Allen Lutz 73% 1-year accuracy 8 / 11 met price target | 31%downside $18 | Underperform Downgraded | 14 Nov 2024 |
Deutsche Bank George Hill 50% 1-year accuracy 5 / 10 met price target | 3%upside $27 | Hold Maintained | 6 Nov 2024 |
Financial journalist opinion
Based on 29 articles about HIMS published over the past 30 days
Neutral
The Motley Fool
1 day ago
Hims & Hers Stock: Growth, Noise, and Where to Focus Now
Hims & Hers Health (HIMS -7.67%) stock is on a downward trend on both macro trends and news about GLP-1s. But this is still a growth stock investors should watch, which Travis Hoium explains in this video.
Negative
Schaeffers Research
1 day ago
Hims and Hers Health Stock Testing Key Trendline
Hims & Hers Health Inc (NYSE:HIMS) stock is sitting out the broad market rally today, last seen down 8.4% to trade at $26.15.
Negative
Finbold
3 days ago
CEO of HIMS dumps over $6 million of stock
Telehealth — a new frontier in healthcare that seeks to apply the creature comforts of the digital age to medical services is a field that carries much promise. However, most telehealth stocks haven't exactly been performing well as of late.
Positive
Zacks Investment Research
5 days ago
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Positive
Zacks Investment Research
5 days ago
HIMS Stock Surges 43% in a Month: Will the Uptrend Continue Further?
Hims & Hers Health, Inc. HIMS has emerged as a transformative player in the personalized healthcare market, showcasing robust growth in 2024. Shares of the company have risen 43% in the past month, significantly outperforming the industry's growth of 5.5%.
Neutral
Business Wire
1 week ago
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
SAN FRANCISCO--(BUSINESS WIRE)--For most Americans, weight is more than just a number. It shapes our health, our mood, our confidence, our spending, and the decisions we make in our day to day lives. In fact, 75% of us think about our weight every single day, and 14% say it's constantly on our minds. At Hims & Hers (NYSE: HIMS), we know that health is personal, which is why we focus on making high-quality, affordable personalized health and wellness solutions to our customers. Along with pr.
Positive
Seeking Alpha
1 week ago
Hims & Hers: Look At What Matters Most
Hims & Hers Health, Inc. has shown significant improvement in key unit economics, positioning it among top-tier SaaS companies in terms of scalability and growth potential. The company reported stellar Q3 FY2024 results with a 77% YoY revenue increase, driven by strong subscriber growth and high retention rates in personal health services. Despite regulatory risks and competition, HIMS' advanced tech platform and focus on personalized healthcare provide a strong foundation for long-term shareholder value.
Positive
MarketBeat
1 week ago
4 Stocks That Crushed Analyst Estimates by More Than Double
Every earnings season has its share of winners and losers, as well as top and bottom-line surprises and disappointments. This recent earnings season is no different.
Negative
CNBC Television
1 week ago
Options Action: Bearish bets on Hims
Mike Khouw joins 'Fast Money' to talk the options trade around Hims.
Positive
CNBC Television
1 week ago
Market Navigator: Hims & Hers Health up 250% in 2024
Todd Gordon, founder of Inside Edge Capital, joins CNBC's 'Power Lunch' to discuss why he's keeping an eye on shares of these healthcare picks, potential headwinds, and more.
Charts implemented using Lightweight Charts™